Expanding Audiology Expertise
Nicholas Reed, Au.D., is faculty in the department of epidemiology at the Johns Hopkins Bloomberg School of Public Health and an audiologist at the Johns Hopkins University School of Medicine.
A renowned expert in hearing care, Dr. Reed has made contributions to the ongoing public dialogue on the state of hearing care in the US, where fewer than 20% of adults with hearing loss own and use hearing aids. His research focuses on over-the-counter hearing care, the impact of hearing loss on patient-provider communication, and the impact of hearing loss on healthcare utilization.
“Dr. Reed’s research and clinical focus on sustainable hearing interventions align perfectly with Neosensory’s mission to revolutionize access to hearing care through our innovative technology,” said David Eagleman, CEO of Neosensory. “We are delighted to welcome Dr. Reed to our medical advisory board and look forward to collaborating with him as we continue to develop breakthrough hearing solutions through advancements in neuroscience.”
“Neosensory is advancing hearing science through research in neuroscience and haptics. The gap in hearing health in the United States is hindered by a lack of innovation in the traditional hearing care marketplace that creates limitations in available options to suit different patient needs, preferences, and values. Neosensory has broken the mold to create a novel method for improving hearing health.”
–Nicholas Reed, Au.D
At Johns Hopkins, Dr. Reed oversees the integration of hearing measures and hearing care into cohort studies and clinical trials. He currently manages hearing data collection the Baltimore Longitudinal Study of Aging, the Atherosclerosis Risk in Communities Neurocognitive Study, the BIOCARD Study, the Baltimore Epidemiologic Catchment Area Study, National Health Aging and Trends Study, and The Longitudinal Aging Study of India. In addition, he is a co-investigator in the landmark Aging and Cognitive Health Evaluation in Elders (ACHIEVE) trial aiming to understand the impact of hearing care on cognitive trajectories among adults with hearing loss.
Tech Executive and Industry Thought Leader
Katie McMahon has joined the company as a strategic business advisor. Katie is a global entrepreneur and technology executive, with a dynamic career spent in sound recognition and voice AI space, first as a VP at Shazam in London and later VP and GM at SoundHound in Silicon Valley. She is credited with guiding Shazam’s breakout success as one of the first apps to launch on the iPhone, and she led the product to becoming an iconic utility which is now integrated on iPhones.
McMahon’s experience in launching consumer products and software platforms brings additional perspective on opening opportunities with third-party developers and creators to enable new immersive experiences through augmented senses.
As a pioneer in the mobile era, McMahon has over twenty years of experience in helping companies bring innovations from the lab to product creation and product-market fit. She worked in Japan at the world’s first mobile virtual network operator (MVNO) and later launched a MVNO company in Tokyo, combining hardware, software, and value-added service to sell direct-to-consumer. Recipient of the the Project Voice “Outstanding Achievement Award,” McMahon is considered a thought leader across the Voice AI industry and has been a trusted advisor to start-ups and growth-stage founders.
“With global experience across mobile, sound recognition, voice AI and AR, Katie brings unique operator experience in taking early-stage technologies and getting them into the hands of daily users, creating profound new user habits,” said Dr. Eagleman, CEO and Co-founder of Neosensory. “She connects the dots and knows how to build towards the white space. With strong partnership development experience, her guidance for enabling new technologies for distribution and ultimately scale to the mass market has great value for us. We are thrilled to work with her and activate her talent in our journey to change lives through Neosensory’s technology.”
“The rare combination of truly visionary concepts, rooted in neuroscience, and a team which can execute across hardware and software is what makes Neosensory extraordinary. I’m thrilled to work with the team of talented people at Neosensory, where we can make the vision a concrete reality. In years to come, we can look forward to a better quality of life and sustained connections with loved ones through Neosensory’s augmented hearing solutions. I’m also excited to enable developers and creators to build meaningful use cases that span life-saving utilities to immersive AR/VR and metaverse experiences through sensory augmentation.”
Founded in 2015 by neuroscientists David Eagleman and Scott Novich, Neosensory builds non-invasive brain-machine interfaces to create new senses.
Dr. Eagleman demonstrated the company’s first sensory substitution device, the VEST, in a widely acclaimed TED Talk. A more compact version of the device, a wristband called Buzz, debuted in 2020. Since then, Neosensory has built a growing community of users, developers, and neurotech enthusiasts. The company’s breakthrough tinnitus program, Neosensory Duo, launched in early 2021, is based on new scientific research on bimodal stimulation. For more information on Neosensory, visit neosensory.com.